SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-035577
Filing Date
2020-02-13
Accepted
2020-02-13 16:14:32
Documents
5
Period of Report
2020-02-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d887803d8k.htm 8-K 29474
2 EX-1.1 d887803dex11.htm EX-1.1 164893
3 EX-5.1 d887803dex51.htm EX-5.1 6588
4 EX-99.1 d887803dex991.htm EX-99.1 9378
5 EX-99.2 d887803dex992.htm EX-99.2 9541
  Complete submission text file 0001193125-20-035577.txt   221221
Mailing Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139 7819626030
AVROBIO, Inc. (Filer) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38537 | Film No.: 20610691
SIC: 2836 Biological Products, (No Diagnostic Substances)